J. McNatt

发表

Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.

M. Rosolowsky, J. Willerson, P. Golino, 1990, The Journal of clinical investigation.

Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.

J. Willerson, P. Golino, L. Buja, 1990, Journal of the American College of Cardiology.

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.

M. Rosolowsky, H. Anderson, C. Benedict, 1992, Circulation research.

Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.

D. Bilheimer, P. Apprill, L. Buja, 1985, Journal of the American College of Cardiology.

Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.

D. Johnston, J. Willerson, J. McNatt, 1995, Circulation research.

Local Gene Transduction of Cyclooxygenase-1 Increases Blood Flow in Injured Atherosclerotic Rabbit Arteries

J. Willerson, J. McNatt, G. Bobustuc, 2005, Circulation.

Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene.

F. Clubb, J. Willerson, R. S. Meidell, 1996, Circulation.

Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries

F. Clubb, H. Anderson, M. Herman, 2001, Circulation.

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Janice, J. Eidt, J. Willerson, 1989, The Journal of clinical investigation.

Cyclic flow alterations and neointimal proliferation following experimental coronary stenosis and endothelial injury

H. Anderson, C. Benedict, J. Willerson, 1993 .

Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor.

J. Willerson, Yasutaka Yamamoto, J. McNatt, 2000, Circulation.

Thromboxane A2 and Serotonin are Possible Mediators

Anne L. Taylor, M. Rosolowsky, W. Campbell, 2005 .

Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.

M. Rosolowsky, W. Campbell, J. Willerson, 1989, Circulation.

Abolition of Cyclic Flow Variations in Stenosed, Endothelium‐Injured Coronary Arteries in Nonhuman Primates With a Peptide Fragment (VCL) Derived From Human Plasma von Willebrand Factor–Glycoprotein Ib Binding Domain

J. Willerson, L. Buja, A. Mcghie, 1994, Circulation.

Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.

M. Triggiani, M. Condorelli, M. Chiariello, 1993, Circulation.

Endothelium-Injured Canine Coronary Arteries

M. Rosolowsky, H. Anderson, C. Benedict, 2005 .

Intra-Arterial Transplantation of Adult Bone Marrow Cells Restores Blood Flow and Regenerates Skeletal Muscle in Ischemic Limbs

J. Willerson, J. McNatt, P. Zoldhelyi, 2009, Vascular and endovascular surgery.

Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.

J. Eidt, H. Anderson, J. Willerson, 1992, The American journal of physiology.

Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.

H. Anderson, J. Willerson, L. Buja, 1994, Circulation.

Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.

M. Rosolowsky, C. Benedict, W. Campbell, 1990, Journal of molecular and cellular cardiology.

Cyclic coronary artery flow in dogs after coronary angioplasty

H. Anderson, J. Willerson, L. Buja, 1990 .

Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.

J. Eidt, J. Willerson, P. Golino, 1989, The American journal of physiology.

Gene therapy to restore prostacyclin presence to injured endothelium.

K. Wu, J. McNatt, J. Willerson, 1995, Transactions of the American Clinical and Climatological Association.

Role of new antiplatelet agents as adjunctive therapies in thrombolysis.

J. Eidt, J. Willerson, P. Golino, 1991, The American journal of cardiology.

Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.

M. Rosolowsky, C. Benedict, W. Campbell, 1990, Journal of Molecular and Cellular Cardiology.

Coronary thrombolysis with a variant of human tissue-type plasminogen activator in a canine preparation: Slightly enhanced thrombolysis and prolonged time to reocclusion

J. Eidt, J. Willerson, L. Buja, 1991 .

Reperfusion Adjunctive Therapy: Platelet Active Agents

J. Willerson, P. Golino, L. Buja, 1990 .

MYOCARDIAL ISCHEMIA Cooperative mediation by serotonin S 2 and thromboxane A 2 / prostaglandin H 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses

Anne L. Taylor, W. Campbell, J. Willerson, 2005 .

Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.

P. Golino, L. Buja, J. McNatt, 1989, Journal of the American College of Cardiology.

Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries

J. Willerson, J. McNatt, H. Shelat, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

J. Willerson, P. Golino, L. Buja, 1988, Circulation.

Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.

J. Eidt, H. Anderson, J. Willerson, 1991, Journal of the American College of Cardiology.

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

R. O'brien, J. Willerson, P. Golino, 1989, Circulation.

Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.

H V Anderson, C R Benedict, H. Anderson, 1991, Proceedings of the National Academy of Sciences of the United States of America.

thrombosis after tissue-type plasminogen activator in a canine model of coronary reocclusion antagonists markedly enhances thrombolysis and prevents or delays Simultaneous administration of thromboxane A2- and serotonin S2- receptor

R. O'brien, J. Willerson, P. Golino, 2011 .

Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor.

R. Dixon, F. Clubb, E. Yeh, 2000, American journal of physiology. Heart and circulatory physiology.

Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.

J. Eidt, J. Willerson, P. Golino, 1989, The Journal of clinical investigation.

ThrombinIsan Important Mediator ofPlatelet Aggregation inStenosed CanineCoronary Arteries withEndothelial Injury

J. McNatt, J. Ashton, 1989 .

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.

W. Campbell, J. Willerson, P. Golino, 1987, Circulation.

Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.

J. Eidt, J. Willerson, P. Golino, 1991, Molecular biology & medicine.

Combined ADP and Thromboxane A2 Antagonism Prevents Cyclic Flow Variations in Stenosed and Endothelium‐Injured Arteries in Nonhuman Primates

J. Maffrand, L. Buja, S. Yao, 1993, Circulation.